about
Xanthurenic acid binds to neuronal G-protein-coupled receptors that secondarily activate cationic channels in the cell line NCB-20Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain.Endogenous morphine in SH-SY5Y cells and the mouse cerebellumgamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo.[A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse].Neurophysiological responses to unpleasant stimuli (acute electrical stimulations and emotional pictures) are increased in patients with schizophrenia.Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death.Calcium and cAMP signaling induced by gamma-hydroxybutyrate receptor(s) stimulation in NCB-20 neurons.Xanthurenic acid distribution, transport, accumulation and release in the rat brain.Skeletal muscle ischemia-reperfusion injury and cyclosporine A in the aging rat.Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.Evidence for effective structure-based neuromodulatory effects of new analogs of neurosteroid allopregnanolone.Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension.Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain.Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum.Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older ChildrenVentricular bigeminy associated with voriconazole, methadone and esomeprazoleProtective effect of 4-Phenylbutyrate against proteolipid protein mutation-induced endoplasmic reticulum stress and oligodendroglial cell deathOptimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach
P50
Q28484900-11132EA9-33CD-4FAA-A0B5-49FE2C011C76Q33267966-40051EC0-2E18-4C3F-95CD-519BF1C138A2Q33323041-43D18C1A-2FEB-4FDD-9EF7-F8DCDC59BE46Q33866058-C3402107-B9AE-4329-9E03-21BAB0BE1155Q34399794-66E96DC0-3B6F-4D87-92E1-5F41E228CAF7Q36645191-507EABE6-2115-4334-8684-23C2C5D0C75EQ39031366-0D70E861-27EF-4888-9795-3DEE23302AD0Q39739978-F03545DF-9836-4427-A083-B30ED34DE37EQ40027314-78A41037-1CCA-43F0-ADC4-63ADAB451E95Q40085982-6A9546AB-BD7E-444F-8C4A-18B3E386D619Q41649404-A7F510C6-BF35-4759-AE80-13B60BB347D6Q42859819-F78A6C7A-B530-4BFA-8CFF-2A2725A55514Q42982204-14AAE0AC-3110-4E5B-A668-97E5B1C69843Q47562333-79CA515D-E041-455A-A0E3-34FDAF6FC180Q47794494-77AC87F3-FC2B-4E11-9D9D-319552983475Q48460414-A5715DC8-EBB3-498A-BB55-7FE0E91F528BQ51375608-AB37971A-5306-4395-A67B-F77DE38FD6F1Q57131790-43F2D390-5628-44A9-A847-5F45185F6C32Q61758307-037C144A-E246-432A-9780-51B175FB3145Q89218563-1398152D-C5A7-4050-8A74-A74182A31F19Q90775172-057EC530-A6DF-45A0-BA9D-54B9A5C493EC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Véronique Kemmel
@ast
Véronique Kemmel
@en
Véronique Kemmel
@es
Véronique Kemmel
@nl
Véronique Kemmel
@sl
type
label
Véronique Kemmel
@ast
Véronique Kemmel
@en
Véronique Kemmel
@es
Véronique Kemmel
@nl
Véronique Kemmel
@sl
prefLabel
Véronique Kemmel
@ast
Véronique Kemmel
@en
Véronique Kemmel
@es
Véronique Kemmel
@nl
Véronique Kemmel
@sl
P106
P1153
6507701760
P21
P31
P496
0000-0003-4680-4293